Moreover, combined examination of NMB and CCL2 showed the discrimination of PNI with the AUC value of 0.914 (95% CI 0.828-1.000) in cervical cancer as compared to that of NMB or CCL2 alone, which may be clinical effective for the preoperative evaluation of PNI. The gene discussed is NMB; the disease is cervical carcinoma.